Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/75923
Campo DC Valoridioma
dc.contributor.authorCrisostomo, Veronicaen_US
dc.contributor.authorSong, Ho Youngen_US
dc.contributor.authorMaynar Moliner, Manuelen_US
dc.contributor.authorSun, Feien_US
dc.contributor.authorSoria, Federicoen_US
dc.contributor.authorLima, Juan Rafaelen_US
dc.contributor.authorYoon, Chang Jinen_US
dc.contributor.authorUson-Gargallo, Jesusen_US
dc.date.accessioned2020-11-24T15:39:01Z-
dc.date.available2020-11-24T15:39:01Z-
dc.date.issued2007en_US
dc.identifier.issn0174-1551en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/75923-
dc.description.abstractTo evaluate the effect of temporary stent placement on the canine prostatic urethra.Retrievable PTFE-covered nitinol stents were placed in the prostatic urethras of 8 beagle dogs under fluoroscopic guidance. Retrograde urethrography was obtained before and after stenting. Retrograde urethrography and endoscopy were performed 1 and 2 months after deployment. The endoscopic degree of hyperplasia was rated on a scale of 0 to 4 (0 = absence, 4 = occlusion). On day 60, stents were removed and urethrography was performed immediately before euthanasia. Pathologic analysis was performed to determine the degree of glandular atrophy, periurethral fibrosis, and urethral dilation.Stent deployment was technically successful in 7 animals, and failed in 1 dog due to a narrow urethral lumen. Complete migration was seen in 2 animals at 1 month, and an additional stent was deployed. On day 30, endoscopy showed slight hyperplasia (grade 1) in 3 animals. On day 60, moderate hyperplasia (grade 2) was evidenced in 4 cases. No impairment of urinary flow was seen during follow-up. Retrieval was technically easy to perform, and was successful in all dogs. The major histologic findings were chronic inflammatory cell infiltrates; prostate glandular atrophy, with a mean value of 1.86 (SD 0.90); periurethral fibrosis, with a mean ratio of 29.37 (SD 10.41); and dilatation of the prostatic urethra, with a mean ratio of 6.75 (SD 3.22).Temporary prostatic stent placement in dogs is safe and feasible, causing marked enlargement of the prostatic urethral lumen. Retrievable covered stents may therefore be an option for bladder outlet obstruction management in men.en_US
dc.languageengen_US
dc.relation.ispartofCardioVascular and Interventional Radiologyen_US
dc.sourceCardiovascular And Interventional Radiology [ISSN 0174-1551], v. 30 (4), p. 731-737, (Julio 2007)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320111 Radiologíaen_US
dc.subject.otherUrolume Endoprosthesisen_US
dc.subject.otherHigh-Risken_US
dc.subject.otherHyperplasiaen_US
dc.subject.otherExperienceen_US
dc.subject.otherRemovalen_US
dc.subject.otherFeasibilityen_US
dc.subject.otherObstructionen_US
dc.subject.otherSphincteren_US
dc.subject.otherWallstenten_US
dc.subject.otherCatheteren_US
dc.subject.otherExperimental Studyen_US
dc.subject.otherProstate Stenten_US
dc.subject.otherRetrievable Stentsen_US
dc.titleEvaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: Short-term study in the canine modelen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s00270-007-9006-9en_US
dc.identifier.scopus36048946344-
dc.identifier.isi000248831000023-
dc.contributor.authorscopusid8537585200-
dc.contributor.authorscopusid24503444900-
dc.contributor.authorscopusid7005962555-
dc.contributor.authorscopusid57085682500-
dc.contributor.authorscopusid7006974018-
dc.contributor.authorscopusid7202778155-
dc.contributor.authorscopusid7202882827-
dc.contributor.authorscopusid6603379138-
dc.identifier.eissn1432-086X-
dc.description.lastpage737en_US
dc.identifier.issue4-
dc.description.firstpage731en_US
dc.relation.volume30en_US
dc.type2Artículoen_US
dc.contributor.daisngid492319-
dc.contributor.daisngid61313-
dc.contributor.daisngid30319800-
dc.contributor.daisngid1483572-
dc.contributor.daisngid31974070-
dc.contributor.daisngid4037082-
dc.contributor.daisngid179576-
dc.contributor.daisngid1371671-
dc.description.numberofpages7en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Crisostomo, V-
dc.contributor.wosstandardWOS:Song, HY-
dc.contributor.wosstandardWOS:Maynar, M-
dc.contributor.wosstandardWOS:Sun, F-
dc.contributor.wosstandardWOS:Soria, F-
dc.contributor.wosstandardWOS:Lima, JR-
dc.contributor.wosstandardWOS:Yoon, CJ-
dc.contributor.wosstandardWOS:Uson-Gargallo, J-
dc.date.coverdateJulio 2007en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr1,251
dc.description.jcrqQ3
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Tecnología Médica y Audiovisual-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-9154-0712-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameMaynar Moliner,Manuel-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

11
actualizado el 24-nov-2024

Citas de WEB OF SCIENCETM
Citations

8
actualizado el 24-nov-2024

Visitas

117
actualizado el 31-ago-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.